Brief: Waverley Pharma Business Update

Waverley Pharma

02/08/2023 23:35

Aug 2 (Reuters) - Waverley Pharma Inc  WAVE.V :
    * WAVERLEY PHARMA BUSINESS UPDATE
    * WAVERLEY PHARMA INC - SHIFTING FOCUS BACK TO DEVELOPMENT
OF
NOVEL DRUGS, LIKE EXISTING PARP-1 INHIBITOR PROJECT
    * WAVERLEY PHARMA: BUSINESS OPPORTUNITY ENVISIONED OF
EXPANDING
FOCUS BEYOND DEVELOPMENT OF NOVEL ONCOLOGY DRUGS HAS NOT
MATERIALIZED AS PLANNED
    * WAVERLEY PHARMA INC: BUSINESS OPPORTUNITY PLAN HAD
INCLUDED
MARKETING RECENTLY OFF PATENT GENERIC ONCOLOGY DRUGS
    * WAVERLEY PHARMA: REASON FOR SHIFTING FOCUS BACK HAS BEEN
"UNPRECEDENTED" DISCOUNT IN PRICING VERSUS BRAND IN GENERIC
INDUSTRY AS SOON AS IT IS OFF PATENT

Source text for Eikon:  ID:nCNWd0tT6a 
Further company coverage:  WAVE.V 

 ((Reuters.Briefs@thomsonreuters.com;))